Generics and Epilepsy: When Is It Safe to Substitute a Generic Medication?(webMD)
SJCRG: CLICK HERE for a webMD discussion on the efficacy of generic medication for Epilepsy.
http://www.aan.com/globals/axon/assets/2323.pdf
SJCRG: CLICK HERE for position paper of the AAN
Quoting the AAN:
“…The AAN opposes generic substitution of anticonvulsant drugs for the treatment
of epilepsy without the attending physician’s approval….”
SJCRG: What about the generics at large for other diseases. Certainly most generics are effective, but all? Don’t we needs an efficacy study for each, beyond FDA assurances of similarity.
Or are we going to accept casualties as the normal way to do business in the great war against cost?
Tags: AAN, careresourceguide, Cost, Coverage, effecacy, epilepsy, Generics, healthcare, insurance, Medical drugs, medication, SJCRG, webMD
This entry was posted
on Monday, February 22nd, 2010 at 3:03 pm and is filed under Medicare, Pharmaceuticals, coverage, insurance, medicaid.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
